Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360042
Status:
RECRUITING
Last Update Posted:
2024-04-22
First Post:
2024-02-27
Brief Title:
Anti-PD-1PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC
Sponsor:
Peking University Cancer Hospital Institute
Organization:
Peking University Cancer Hospital Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Unresectable Hepatocellular Carcinoma |
Keywords: